Taking a long-horizon approach to public equities, the firm targets high-quality businesses with durable cash flows and compounding potential. Smead Capital Management runs concentrated, low-turnover long-only portfolios that blend value and growth discipline and deploys capital via mutual funds and institutional separate accounts. The investment team emphasizes fundamental research, downside risk control and active engagement with managements; the firm is a steady large-cap equity holder that influences outcomes through patient ownership.
Taking a long-horizon approach to public equities, the firm targets high-quality businesses with durable cash flows and compounding potential. Smead Capital Management runs concentrated, low-turnover long-only portfolios that blend value and growth discipline and deploys capital via mutual funds and institutional separate accounts. The investment team emphasizes fundamental research, downside risk control and active engagement with managements; the firm is a steady large-cap equity holder that influences outcomes through patient ownership.
Long-horizon public-equity investor focused on concentrated, low-turnover portfolios of high-quality, cash-generative businesses. Combines disciplined value and growth analysis to identify compounding opportunities, emphasizes fundamental research, downside protection and active stewardship, and deploys capital through mutual funds and institutional separate accounts. Prefers large-cap, durable franchises where patient ownership and engagement can influence outcomes; risk-controlled sizing and capital preservation guide allocation and holding periods measured in years.
Long-horizon public-equity investor focused on concentrated, low-turnover portfolios of high-quality, cash-generative businesses. Combines disciplined value and growth analysis to identify compounding opportunities, emphasizes fundamental research, downside protection and active stewardship, and deploys capital through mutual funds and institutional separate accounts. Prefers large-cap, durable franchises where patient ownership and engagement can influence outcomes; risk-controlled sizing and capital preservation guide allocation and holding periods measured in years.
| Trades 2125 | Longs Won 1545/2125 72% | Profit Factor 6.15 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $6.64M |
| Average Win $3.11M | Best Trade (Dec 30) $92.99M | Sharpe Ratio -10.17 |
| Average Loss -$1.35M | Worst Trade (Jun 30) -$26.01M | Z-Score -11.04 (100%) |
| Commissions $0 | Avg. Trade Length 2y 11m 2w 4d | Expectancy $1.89M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 3,717 | 3,346 | 2,974 | 2,602 | 2,230 | 1,859 | 1,487 | 1,115 | 743 | 372 |